New Biology Economy

New Biology Economy tracks news of the emerging molecular biology tools marketplace, which is building on foundational biotechnical advances to create new insights into complex biological systems. This blog begins with the understanding that traditional business methods must change to enable innovation to create wealth and eventually benefit patients. This will require cooperation, new ways of protecting intellectual property, and will spawn new types of business organizations.

Google
WWW New Biology Economy

Friday, November 18, 2005

India and Israel Link Up to Commercialize Technology Innovation as Funding Flows In

  • India and Israel will begin a technology commercialization collaboration early in 2006, VS Ramamurthy, India's science and technology secretary, told the Indo-Asian News Service in an article widely distributed in the India press.
    "Israel will be our first research and development partner for commercialization of innovations,” Ramamurthy said.

    India's announcement of the joint venture comes as private-equity funding expands in the country.
    "While the government accounts for over 80 percent of investment in research and development, the increasing risk-taking appetite of the private sector for innovation is seeing considerable activity and investment,” Ramamurthy added in the IANS article, available here.

    According to a Reuters report, Private equity funds raised $260 million to invest in India in 2003, but by June, new funds already topped $500 million, according to researchers at the Asian Venture Capital Journal.

    India's economy may grow as much as 8 percent this year while expanding at a 5-percent rate since the start of the decade, compared to less than 2 percent growth in Europe on a 10-year average and 3 percent growth in the US.

    Private equity investment in India has more than doubled in 12 months to about $2 billion, Amrish Baliga, head of the private capital practice at ICICI Securities, told the online publication Daily News India. This investment is, however, is targeting listed companies, Nitin Deshmukh, head of private equity at Kotak Mahindra Bank, told the publication.

    Meantime, International Finance Corporation (IFC), a member of the World Bank Group, will invest about $ 300 million in another 3-5 years in pharmaceutical, biotech and healthcare companies in India, according to reports.

  • 0 Comments:

    Post a Comment

    << Home

    Blogarama - The Blog Directory Business Blog Top Sites